Patient assistance programs (PAPs) are programs created by drug companies,
such as SHIRE PHARMACEUTICALS, to offer free or low cost drugs to individuals who are unable to
pay for their medication. These Programs may also be called indigent drug programs,
charitable drug programs or medication assistance programs. Most of the best known and
most prescribed drugs can be found in these programs. All of the major drug companies
have patient assistance programs, although every company has different eligibility and
application requirements.
The SHIRE PHARMACEUTICALS patient assistance program offers free medication to people
who otherwise cannot afford their medications. Patients must meet financial and other
program specific criteria to be eligible for assistance.
For a complete listing of SHIRE PHARMACEUTICALS medications available through
their patient assistance programs, see below:
OnePath Co-Pay Assistance Program
|
|
The medications available through this program are:
|
|
Cinryze
(c1 esterase inhibito) |
|
|
Elaprase Solution
(idsulfase) |
|
|
Firazyr Injection
(icatibant) |
|
|
VPRIV Injection
(velaglucerase alfa) |
|
|
OnePath Patient Assistance Program
|
|
The medications available through this program are:
|
|
Cinryze
(c1 esterase inhibito) |
|
|
Elaprase Solution
(idsulfase) |
|
|
Firazyr Injection
(icatibant) |
|
|
Gattex Injectable
(teduglutide) |
|
|
Natpara Injection
(parathyroid hormone) |
|
|
VPRIV Injection
(velaglucerase alfa) |
|
|
Shire Cares Patient Assistance & Support
|
|
The medications available through this program are:
|
|
Carbatrol
(carbamazepine) |
|
|
Fosrenol
(lanthanum carbonate) |
|
|
Intuniv Extended Release Tablets
(guanfacine) |
|
|
|
|
Mydayis
((mixed salts of a single-entity amphetamine product) |
|
|
|
|
Vyvanse
(lisdexamfetamine dimesylate capsules) |
|
|
Xiidra
(lifitegrast ophthalmic solution)) |
|
|